Browse All
Displaying 1 - 2 of 2
Author:Morrow, Sarah Hancock, Laura Nonino, Francesco Desantis, Claudia Schettino, Martino Langdon, Dawn Amato, Maria Pia Schoonheim, Menno
Session Name:P1: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 1
Topic:Multiple Sclerosis
Program Number:P1.011
Author Institution:University of Calgary, Hotchkiss Brain Institute, calgary, AB, Canada Cleveland Clinic, Cleveland, OH Cochrane Review Group Multiple Sclerosis and Rare Diseases of the CNS, Italy Royal Holloway, Egham, United Kingdom University of Florence, Italy Amsterdam University Medical Center, Amsterdam, Netherlands
Author:Pardo, Gabriel Montalban, Xavier Cohen, Jeffrey Morrow, Sarah Li, Jun Carr, David Pearce, Gregory Solonets, Maria Abeyewickreme, Anil de Seze, Jérôme Nakahara, Jin Wiendl, Heinz Hauser, Stephen
Session Name:P9: Multiple Sclerosis: Clinical Trials 2
Program Number:P9.006
Author Institution:Oklahoma Medical Research Foundation, Oklahoma City, OK, USA, Oklahoma City, OK Department of Neurology/Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d’Hebron, Barcelona, Spain, Barcelona, Spain Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada, calgary, AB, Canada Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland IQVIA RDS GmbH, Frankfurt, Germany, Germany Novartis Pharmaceuticals UK Ltd, London, United Kingdom, London, United Kingdom University Hospital of Strasbourg, Strasbourg, France, Strasbourg, France Department of Neurology, Keio University School of Medicine, Tokyo, Japan, Shinjuku-ku, Japan Klinik für Neurologie und Neurophysiologie, Universitätsklinikum Freiburg, Freiburg, Germany, Freiburg im Breisgau, Germany UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, USA, San Francisco, CA
